ClassID:

21647

A61K2300/00 - page 51 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#15001
20090092680
2009-04-09

PREPARATION FOR TREATMENT OF MINERAL DEFICIENCY

#15002
20090092674
2009-04-09

Flowable wound matrix and its preparation and use

#15003
20090092670
2009-04-09

Long acting dual release product containing carbinoxamine and pseudoephedrine

#15004
20090092658
2009-04-09

NOVEL FORMULATIONS OF PROTON PUMP INHIBITORS AND METHODS OF USING THESE FORMULATIONS

#15005
20090092657
2009-04-09

Amino acid combinant omega oil aphrodisiac

#15006
20090092656
2009-04-09

Method of treating atrophic vaginitis

#15007
20090092598
2009-04-09

Antibody therapy

#15008
20090092591
2009-04-09

Use of a Mixture of Superoxide Dismutase and Catalase for Treating Inflammatory Skin Lesions

#15009
20090092576
2009-04-09

Antifungal treatment of nails

#15010
20090092574
2009-04-09

Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof

#15011
20090092560
2009-04-09

TRIVALENT CHROMIUM COMPOUNDS, COMPOSITIONS AND METHODS OF USE

#15012
20090090367
2009-04-09

Method of contraception

#15013
20090088471
2009-04-02

Chemical sterilant for adult male dog population control with concomitant reduction in human dog-bite acquired rabies

#15014
20090088449
2009-04-02

4-ACYLAMINOPYRIDINE DERIVATIVE MEDIATED NEUROGENESIS

#15015
20090088423
2009-04-02

METHODS AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS AND DISEASES ASSOCIATED THEREWITH

#15016
20090088410
2009-04-02

Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies

#15017
20090088408
2009-04-02

PHARMACEUTICAL COMPOSITIONS ON ANTICHOLINERGICS, CORTICOSTEROIDS AND BETAMIMETICS

#15018
20090088401
2009-04-02

In-situ cancer autovaccination with intratumoral stabilized dsRNA viral mimic

#15019
20090088397
2009-04-02

Substituted triazolo[1,5-A]pyrimidines as antiviral agents

#15020
20090088394
2009-04-02

METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT

#15021
20090088371
2009-04-02

COMBINATION THERAPY WITH SYK KINASE INHIBITOR

#15022
20090088369
2009-04-02

GLP-1 AND METHODS FOR TREATING DIABETES

#15023
20090087504
2009-04-02

Method for treating diabetic complications

#15024
20090087503
2009-04-02

Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals

#15025
20090087498
2009-04-02

Shampoo formulation for treatment of hair loss and method of use

#15026
20090087497
2009-04-02

Compositions and methods for treating symptoms of aging

#15027
20090087481
2009-04-02

Methods of treating neurological conditions with hematopoeitic growth factors

#15028
20090087480
2009-04-02

Pharmaceutical composition and method using antifungal agent in combination

#15029
20090087451
2009-04-02

Methods and compositions for vaccination

#15030
20090087450
2009-04-02

Combination therapy of hybrid cells with BCG injection for treating Cancer Patients

#15031
20090087441
2009-04-02

Wortmannin analogs and methods of using same in combination with chemotherapeutic agents

#15032
20090087440
2009-04-02

Methods for Treating Cancer

#15033
20090087432
2009-04-02

TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES

#15034
20090087431
2009-04-02

METHODS OF TREATING BONE DISORDERS WITH MODULATORS OF AXL

#15035
20090087417
2009-04-02

METHODS FOR PROMOTING DOPAMINERGIC NEURONAL DEVELOPMENT BY USING NG4A-SUBFAMILY AND WNT-LIGANDS

#15036
20090087407
2009-04-02

METHODS FOR THE TREATMENT OF SCLERODERMA USING 1-OXO-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-METHYLISOINDOLINE

#15037
20090087405
2009-04-02

Use of Lck inhibitors for treatment of immunologic diseases

#15038
20090087404
2009-04-02

METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY

#15039
20090082738
2009-03-26

Natural Anti-Inflammatory Agents for Reducing Pain

#15040
20090082448
2009-03-26

Method for placental exfoliation using oxo-arachidonic acid or the like

#15041
20090082437
2009-03-26

Use of Oxaliplatin for Enhancing Radiosensitivity in Radiotherapy of Cervical Cancer

#15042
20090082424
2009-03-26

SMALL MOLECULE ANTAGONISTS OF BCL-2 FAMILY PROTEINS

#15043
20090082406
2009-03-26

Cancer Therapy

#15044
20090082400
2009-03-26

SOLUBLE PYRONE ANALOGS METHODS AND COMPOSITIONS

#15045
20090082384
2009-03-26

PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

#15046
20090082370
2009-03-26

Pharmaceutical Combinations of PK Inhibitors and Other Active Agents

#15047
20090082338
2009-03-26

Preventive or remedy for glaucoma

#15048
20090082337
2009-03-26

Compositions Comprising Quinolone and Methods for Treating or Controlling Infections

#15049
20090082315
2009-03-26

Compositions and Methods for Controlling Cholesterol Levels

#15050
20090082309
2009-03-26

Method of regulating glucose metabolism, and reagents related thereto

#15051
20090082295
2009-03-26

COMBINATIONS AND METHODS OF USING AN IMMUNOMODULATORY OLIGODEOXYNUCLEOTIDE

#15052
20090082293
2009-03-26

TECHNIQUES AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE BY IN VIVO GENE DELIVERY

#15053
20090082288
2009-03-26

Methods and compositions for the treatment of uveitis

#15054
20090082260
2009-03-26

COMBINATION OF AN IMMUNOSUPPRESSANT AND A PPAR GAMMA AGONIST FOR THE TREATMENT OF AN UNDESIRABLE IMMUNE RESPONSE

#15055
20090082256
2009-03-26

Concomitant pharmaceutical agents and use thereof

#15056
20090082255
2009-03-26

Acidic insulin preparations having improved stability

#15057
20090082207
2009-03-26

Growth hormone-containing formulation and method of use

#15058
20090081635
2009-03-26

Modified heparinase III and methods of sequencing therewith

#15059
20090081320
2009-03-26

Method for Weight Reduction

#15060
20090081314
2009-03-26

Glycemic Control, Diabetes Treatment, and Other Treatments with Acetyl Cholinesterase Inhibitors

#15061
20090081311
2009-03-26

Medium chain peroxycarboxylic acid compositions

#15062
20090081303
2009-03-26

Pharmaceutical formulation for contraception and hormone-replacement therapy

#15063
20090081300
2009-03-26

AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE

#15064
20090081278
2009-03-26

Drug delivery system

#15065
20090081276
2009-03-26

BIORESORBABLE IMPLANT COMPOSITION

#15066
20090081274
2009-03-26

MAST CELL-DERIVED RENIN

#15067
20090081206
2009-03-26

METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING PREMATURE RAPTURE OF FETAL MEMBRANES, RIPENING OF UTERINE CERVIX AND PRETERM LABOR IN MAMMALS

#15068
20090081203
2009-03-26

Methods for treating lymphomas in certain patient populations and screening patients for said therapy

#15069
20090081187
2009-03-26

Pharmacological vitreolysis

#15070
20090081186
2009-03-26

Methods and compositions for preventing and/or treating pancreatitis

#15071
20090081184
2009-03-26

NON-PANCREATIC PROTEASES FOR CONTROLLING PLASMA CHOLECYSTOKININ (CCK) CONCENTRATION AND FOR TREATING PAIN

#15072
20090081183
2009-03-26

HIV Transcription Repressor Complex and Compositions and Methods Based Thereon

#15073
20090081179
2009-03-26

Method for reducing the severity of neurological disorders

#15074
20090081177
2009-03-26

Methods and compositions for improving pregnancy outcome

#15075
20090081173
2009-03-26

METHODS AND COMPOSITIONS INVOLVING BACTERIOPHAGE ISOLATES

#15076
20090081167
2009-03-26

Folic acid producing bifidobacterium bacterial strains, formulations and use thereof

#15077
20090081163
2009-03-26

Cladribine regimen for treating multiple sclerosis

#15078
20090081161
2009-03-26

Infection and treatment of neoplasms with vesicular stomatitis virus

#15079
20090081160
2009-03-26

Method for reducing the likelihood of implantation failure during assisted reproduction in a subject

#15080
20090081157
2009-03-26

Immunostimulatory Combinations for Vaccine Adjuvants

#15081
20090081153
2009-03-26

COMBINATION OF SYNTHETIC ANTIMICROBIAL POLYMERS AND SESQUITERPENOID COMPOUNDS

#15082
20090076170
2009-03-19

Stable organic peroxide compositions

#15083
20090076132
2009-03-19

ANTIVIRAL COMPOSITIONS AND METHODS OF TREATMENT

#15084
20090076111
2009-03-19

Methods for improving glycemic control in humans

#15085
20090076108
2009-03-19

METHOD FOR TREATING OBESITY

#15086
20090076053
2009-03-19

METHODS AND COMPOSITIONS FOR TREATING PAIN

#15087
20090076033
2009-03-19

Method for treating atherosclerosis employing an aP2 inhibitor and combination

#15088
20090076021
2009-03-19

THERAPEUTIC COMBINATIONS AND METHODS FOR CARDIOVASCULAR IMPROVEMENT AND TREATING CARDIOVASCULAR DISEASE

#15089
20090076014
2009-03-19

Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring

#15090
20090075976
2009-03-19

Association between an anti-atherothrombotic and an angiotensin-converting enzyme inhibitor

#15091
20090075962
2009-03-19

Growth stimulant compositions

#15092
20090075957
2009-03-19

Xanthohumol compositions and methods of using same

#15093
20090075956
2009-03-19

Genetic Risk Assessment in Heart Failure: Impact of the Genetic Variation of NOS3

#15094
20090075955
2009-03-19

Therapeutic regimens for the treatment of immunoinflammatory disorders

#15095
20090075954
2009-03-19

Soft anticholinergic esters

#15096
20090075951
2009-03-19

Methods and Reagents for the Treatment of Inflammatory Disorders

#15097
20090075950
2009-03-19

Dosage Forms Containing A PPI, NSAID And A Buffer

#15098
20090075949
2009-03-19

Use of dipyridamole in combination with antithrombotics for treatment and prevention of thromboembolic diseases

#15099
20090075919
2009-03-19

Anti-neoplastic compositions comprising extracts of black cohosh

#15100
20090075887
2009-03-19

Treatment with Kallikrein Inhibitors

#15101
20090075886
2009-03-19

Dendritic cell stimulatory factor

#15102
20090075873
2009-03-19

Gastrin compositions and formulations, and methods of use and preparation

#15103
20090075867
2009-03-19

Triazine compounds and compositions thereof for the treatment of cancers

#15104
20090075864
2009-03-19

Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators

#15105
20090074940
2009-03-19

THICKENER COMPOSITION FOR DYSPHAGIA PATIENTS

#15106
20090074895
2009-03-19

COMPOSITION AND USES THEREOF

#15107
20090074889
2009-03-19

Compositions and methods for treatment and prevention of osteoarthritis

#15108
20090074888
2009-03-19

Stable cleanser compositions containing sulfur

#15109
20090074886
2009-03-19

GSK-3 INHIBITORS

#15110
20090074880
2009-03-19

METHOD FOR OXYGEN TREATMENT OF INTACT SKIN

#15111
20090074879
2009-03-19

Wound-Healing Composition

#15112
20090074863
2009-03-19

Dosage Forms Containing A PPI, NSAID And A Buffer

#15113
20090074830
2009-03-19

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#15114
20090074816
2009-03-19

Tissue targeted antigenic activation of the immune response to cancers

#15115
20090074796
2009-03-19

Pde5 inhibitor compositions and methods for immunotherapy

#15116
20090074787
2009-03-19

Anti-CTLA4 Antibody and Indolinone Combination Therapy for Treatment of Cancer

#15117
20090074766
2009-03-19

Methods of inhibiting HIV-2 infection

#15118
20090074761
2009-03-19

Therapeutic beta-glucan combinations

#15119
20090074757
2009-03-19

Antitumor Combination Comprising Substituted Acryloyl Distamycin Derivatives and Antibodies Inhibiting Growth Factors or Their Receptors

#15120
20090074754
2009-03-19

Methods and compositions useful in the treatment of mucositis

#15121
20090074751
2009-03-19

GROWTH FACTOR FRACTION COMPOSITIONS AND METHODS

#15122
20090074744
2009-03-19

Use of collagenase to facilitate guide wire crossing in total arterial occlusions

#15123
20090074739
2009-03-19

Pharmacological vitreolysis

#15124
20090074738
2009-03-19

1-substituted-3-β-D-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same

#15125
20090074736
2009-03-19

IMPLANTABLE PREPARATIONS COMPRISING GLOBIN, PROCESS FOR THEIR PRODUCTION, AND USES

#15126
20090074735
2009-03-19

TOPICAL PRODUCT CONTAINING SACRIFICIAL MATERIAL FOR NEUTRALIZING FREE RADICALS

#15127
20090074729
2009-03-19

AUGMENTATION AND REPAIR OF SPINCTER DEFECTS WITH CELLS INCLUDING FIBROBLASTS

#15128
20090074716
2009-03-19

METHOD FOR TREATING INFLUENZA VIRUS INFECTION

#15129
20090074713
2009-03-19

Dendritic cell tumor injection (DCTI) therapy

#15130
20090074712
2009-03-19

Methods for Treatment and Prevention of Infection

#15131
20090074711
2009-03-19

HUMAN THERAPIES USING CHIMERIC AGONISTIC ANTI-HUMAN CD40 ANTIBODY

#15132
20090074688
2009-03-19

Antimicrobial Lotion Compositions

#15133
20090069638
2009-03-12

Diagnostic and Treatment Regimen for Achieving Body Water Homeostasis

#15134
20090069623
2009-03-12

METHODS AND COMPOSITIONS FOR TREATMENT OR PREVENTION OF RADIATION-INDUCED FIBROSIS

#15135
20090069544
2009-03-12

Humanized antibodies that recognize beta amyloid peptide

#15136
20090069425
2009-03-12

Active composition for treatment or prevention of problems related to a disturbance of the biological clock

#15137
20090069422
2009-03-12

Composition and method for increasing the anabolic state of muscle cells

#15138
20090069420
2009-03-12

Small molecule inhibitors of STAT3 with anti-tumor activity

#15139
20090069418
2009-03-12

Compositions and Methods for the Treatment of Disorders Associated with Aberrant Vasodilation

#15140
20090069414
2009-03-12

Epicatechin and vasodilation

#15141
20090069394
2009-03-12

CANCER TREATMENT WITH EPOTHILONES

#15142
20090069393
2009-03-12

Parenteral formulation for epothilone analogs

#15143
20090069361
2009-03-12

METHODS OF TREATMENT USING (+)- ISOPROPYL 2-METHOXYETHYL 4-(2-CHLORO-3-CYANO-PHENYL)-1, 4-DIHYDRO-2, 6-DIMETHYL-PYRIDINE-3, 5-DICARBOXYLATE

#15144
20090069359
2009-03-12

Topical and transdermal treatments using urea formulation

#15145
20090069345
2009-03-12

Pharmaceutically Stable Compound Consisting of Timolol, Dorzolamide and Brimonidine

#15146
20090069343
2009-03-12

Combination Histamine H1R and H4R Antagonist Therapy for Treating Pruritus

#15147
20090069308
2009-03-12

Use of antihistamine agents for the preventive or early treatment of inflammatory syndromes, in particular those triggered by togaviruses

#15148
20090069277
2009-03-12

Compounds and compositions for treating infection

#15149
20090069240
2009-03-12

METHOD OF PREVENTING AND TREATING ENDOCRINE SYSTEM DISTURBANCES

#15150
20090068300
2009-03-12

PRE- AND POST-WORKOUT FORMULATIONS PROCESSES AND SUPPLEMENT PRODUCTS THEREBY

#15151
20090068295
2009-03-12

Composition for treating cancer and method of using the same

#15152
20090068292
2009-03-12

Therapeutic herb cosmetic composition

#15153
20090068291
2009-03-12

Plant extracts and compositions comprising extracellular protease inhibitors

#15154
20090068290
2009-03-12

BIFEPRUNOX DOSES FOR TREATING SCHIZOPHRENIA

#15155
20090068286
2009-03-12

METHOD OF TREATING CANCER BY ADMINISTRATION OF 5-SUBSTITUTED NUCLEOSIDES

#15156
20090068285
2009-03-12

Calcium phosphate-based materials containing zinc, magnesium, fluoride and carbonate

#15157
20090068278
2009-03-12

USE OF FREE RADICAL SCAVENGERS FOR PROTECTING AND TREATING SKIN AND HAIR DAMAGES CAUSED BY CHEMOTHERAPY

#15158
20090068277
2009-03-12

Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom

#15159
20090068270
2009-03-12

Treatment of degenerated disc with autologous cells

#15160
20090068264
2009-03-12

Clinical Applications of Tetrahydrobiopterin, Lipoic Acid and Their Salts and Methods of Preparing Tetrahydrobiopterin Bis-Lipoate

#15161
20090068262
2009-03-12

Rapid dissolution of combination products

#15162
20090068253
2009-03-12

METHOD FOR THE TREATMENT OF INFECTION WITH HHV-6 VIRUS AND THE AMELIORATION OF SYMPTOMS RELATED TO VIRUS USING LIPOSOMAL ENCAPSULATION FOR DELIVERY OF REDUCED GLUTATHIONE

#15163
20090068243
2009-03-12

Novel formulations for delivery of antiviral peptide therapeutics

#15164
20090068236
2009-03-12

Oral Cephalotaxine Dosage Forms

#15165
20090068214
2009-03-12

Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen

#15166
20090068193
2009-03-12

Treatment And Prophylaxis With 4-1BB-Binding Agents

#15167
20090068192
2009-03-12

Polynucleotides encoding fully human antibodies against human 4-1BB

#15168
20090068190
2009-03-12

ANTI-PROLIFERATIVE COMBINATIONS

#15169
20090068180
2009-03-12

Compositions and methods for treating immunological and inflammatory diseases and disorders

#15170
20090068161
2009-03-12

USE OF A COMBINATION OF HESPERIDIN AND OF A MICROORGANISM FOR INFLUENCING THE BARRIER FUNCTION OF THE SKIN

#15171
20090068155
2009-03-12

Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system

#15172
20090068153
2009-03-12

CELL COMPOSITION FOR TISSUE REGENERATION

#15173
20090068151
2009-03-12

Methods and reagents for the enhancement of virus transduction in the bladder epithelium

#15174
20090068149
2009-03-12

Use of a fermented milk containing for the manufacture of a composition for the prevention or treatment of a delayed-type hypersensitivity reaction

#15175
20090068146
2009-03-12

DIARYL UREAS AND COMBINATIONS

#15176
20090068142
2009-03-12

COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTION AND SARS

#15177
20090068141
2009-03-12

AUTOLOGOUS NATURAL KILLER CELLS AND LYMPHODEPLETING CHEMOTHERAPY FOR THE TREATMENT OF CANCER

#15178
20090068128
2009-03-12

Scar and rosacea and other skin care treatment composition and method

#15179
20090068125
2009-03-12

TREATMENT FOR MUCOSITIS

#15180
20090068110
2009-03-12

ANTIBODIES TO INSULIN-LIKE GROWTH FACTOR RECEPTOR

#15181
20090068098
2009-03-12

ANTIBODIES AND RELATED MOLECULES THAT BIND TO 58P1D12 PROTEINS

#15182
20090068094
2009-03-12

INHIBITORS OF ENDO-EXONUCLEASE ACTIVITY FOR TREATING CANCER

#15183
20090062402
2009-03-05

ACTIVE SUBSTANCE COMBINATION OF LICOCHALCONE A AND PHENOXYETHANOL

#15184
20090062387
2009-03-05

Method of reducing phosphate nephropathy in a mammal

#15185
20090062378
2009-03-05

Nutraceutical mangosteen composition

#15186
20090062377
2009-03-05

ANTI-CANCER COMBINATIONS

#15187
20090062359
2009-03-05

Injectable capsaicin with non-local anesthetic sodium channel-blocker adjunctive agent

#15188
20090062355
2009-03-05

Pharmaceutical Product

#15189
20090062326
2009-03-05

M3 MUSCARINIC RECEPTOR ANTAGONISTS FOR TREATMENT OF M3 MUSCARINIC RECEPTOR-EXPRESSING TUMORS

#15190
20090062319
2009-03-05

Methods of inhibiting the interaction between S100 and the receptor for advanced glycation end-products

#15191
20090062315
2009-03-05

Pharmaceutical acceptable composition containing non-steroidal anti-inflammatory drug and local anesthetics

#15192
20090062309
2009-03-05

Therapeutic compositions for the treatment of cardiovascular diseases and methods for use therefor

#15193
20090062301
2009-03-05

PHARMACEUTICAL COMBINATION COMPOSITION COMPRISING AT LEAST ONE PKC INHIBITOR AND AT LEAST ONE JA K3 KINASE INHIBITOR FOR TREATING AUTOIMMUNE DISORDERS

#15194
20090062249
2009-03-05

Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor

#15195
20090062246
2009-03-05

THERAPEUTIC TREATMENT-014

#15196
20090062242
2009-03-05

METHODS AND COMPOSITIONS FOR TREATING GASTROINTESTINAL CONDITIONS

#15197
20090062240
2009-03-05

Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate

#15198
20090062231
2009-03-05

Appetite Suppressant Composition and Method of Appetite Suppression

#15199
20090062203
2009-03-05

Dipeptidyl peptidase IV inhibitors for the treatment of schizophrenia and depression

#15200
20090062191
2009-03-05

Composition for maintaining gastrointestinal homeostasis

#15201
20090062183
2009-03-05

Modulation of synaptogenesis

#15202
20090061024
2009-03-05

COMPOSITIONS AND METHODS EMPLOYING NMDA ANTAGONISTS FOR ACHIEVING AN ANESTHETIC-SPARING EFFECT

#15203
20090061022
2009-03-05

Pharmaceutical composition comprising arsenite for the treatment of malignancy

#15204
20090061011
2009-03-05

Compositions and methods for delivery of poorly soluble drugs

#15205
20090060997
2009-03-05

PROCESS FOR PRODUCING A PHARMACEUTICAL PREPARATION FOR THERAPEUTIC TREATMENT OF ENDOMETRIOSIS CONTAINING A COMBINATION OF A GESTAGEN AND (6S)-5-METHYLTETRAHYDROFOLATE

#15206
20090060982
2009-03-05

METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS

#15207
20090060972
2009-03-05

DEVICE AND METHOD FOR CELL GRAFTING

#15208
20090060956
2009-03-05

AGENT FOR REDUCING THE USEABLE CALORIE CONTENT OF FOOD AND FOR THERAPEUTIC REDUCTION OF WEIGHT, IN PARTICULAR FOR USE IN THE CASE OF ADIPOSITY (OBESITY)

#15209
20090060944
2009-03-05

Enhancer Of The Effect Of Adrenocorticoid,Comprising Gum Arabic

#15210
20090060943
2009-03-05

Syndrome X Composition and Method of Lowering Blood Pressure and Glycemic Index

#15211
20090060942
2009-03-05

Detoxification Composition and Method of Detoxifying the Body

#15212
20090060941
2009-03-05

Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols

#15213
20090060937
2009-03-05

Immunostimulatory oligonucleotides and uses thereof

#15214
20090060903
2009-03-05

Pharmaceutical compositions comprising an anti-teratogenic compound and applications of the same

#15215
20090060894
2009-03-05

Treatment to aid in the metabolism of alcohol

#15216
20090060879
2009-03-05

Oral Compositions, Products and Methods Of Use

#15217
20090060878
2009-03-05

Oral Compositions, Products And Methods Of Use

#15218
20090060870
2009-03-05

Methods and means for the treatment of HPV induced intraepithelial neoplasia

#15219
20090060868
2009-03-05

Alpha-MSH therapies for treatment of autoimmune disease

#15220
20090060864
2009-03-05

Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies

#15221
20090060852
2009-03-05

Compounds, Formulations and Methods for Reducing Skin Wrinkles, Creasing and Sagging

#15222
20090054537
2009-02-26

Therapeutic protocols using hyaluronan

#15223
20090054532
2009-02-26

Modulators of Retinol-Retinol Binding Protein (RBP)-Transthyretin (TTR) Complex Formation

#15224
20090054530
2009-02-26

Methods and compositions that enhance bioavailability of coenzyme-Q10

#15225
20090054527
2009-02-26

Administration of capsaicinoids

#15226
20090054526
2009-02-26

INHIBITORS OF ANOREXIC LIPID HYDROLYSIS FOR THE TREATMENT OF EATING DISORDERS

#15227
20090054513
2009-02-26

METHOD OF MANAGING BLOOD GLUCOSE LEVELS, INSULIN LEVELS AND/OR INSULIN RECEPTOR FUNCTIONALITY IN INDIVIDUALS WITH DIABETES, POLYCYSTIC OVARIAN SYNDROME AND/OR ALZHEIMER'S DISEASE

#15228
20090054512
2009-02-26

USE OF ORGANIC COMPOUNDS

#15229
20090054473
2009-02-26

THERAPY FOR COMPLICATIONS OF DIABETES

#15230
20090054443
2009-02-26

COMPOSITIONS CONTAINING RIBOFLAVIN AND SESAMIN-CLASS COMPOUNDS

#15231
20090054415
2009-02-26

COMBINATIONS, METHODS AND COMPOSITIONS FOR TREATING CANCER

#15232
20090054414
2009-02-26

Rufinamide for the Treatment of Post-Traumatic Stress Disorder

#15233
20090054404
2009-02-26

USE OF R-10-HYDROXY-10,11-DIHYDRO-CARBAMAZEPINE IN NEUROPATHIC PAIN

#15234
20090054403
2009-02-26

Treatment of Post-Traumatic Stress Disorder

#15235
20090054393
2009-02-26

METHODS FOR TREATING DISORDERS ASSOCIATED WITH HYPERLIPIDEMIA IN A MAMMAL

#15236
20090054386
2009-02-26

Compositions and methods for inducing bone growth and inhibiting bone loss

#15237
20090054384
2009-02-26

Airway alkalinization as therapy for airway diseases

#15238
20090054381
2009-02-26

METHODS FOR TREATING RESPIRATORY DISORDERS

#15239
20090054372
2009-02-26

Combination therapy for weight loss

#15240
20090054371
2009-02-26

Folic acid-, vitamin B6- and vitamin B12-containing agents and the use thereof

#15241
20090054351
2009-02-26

Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases

#15242
20090054343
2009-02-26

Methods of therapy using pharmaceutical composition for thrombin peptide derivatives

#15243
20090054339
2009-02-26

Novel cellular factor-containing solution compositions

#15244
20090054338
2009-02-26

Synergisms between repartitioning and immunomodulating compounds

#15245
20090054330
2009-02-26

Novel Therapeutic Use of Viral Inflammation Modulatory Protein in Blocking Xenograft Rejection

#15246
20090054319
2009-02-26

Methods and Compositions for the Treatment of Hypertension and Gastrointestinal Disorders

#15247
20090054315
2009-02-26

Counteracting drug-induced obesity using GLP-1 agonists

#15248
20090054314
2009-02-26

Combined use of DPP-IV inhibitors and gastrin compounds

#15249
20090054313
2009-02-26

METHOD FOR INDUCING DEPOSITION AND MATURATION OF BONE COMPRISING A CO-THERAPEUTIC REGIMEN OF LMP-1 AND BMP-2

#15250
20090054305
2009-02-26

Mixtures of Amylin and Insulin

#15251
20090054304
2009-02-26

HETEROCYCLIC MODULATORS OF TGR5 FOR TREATMENT OF DISEASE

#15252
20090054303
2009-02-26

Crystal forms of saxagliptin and processes for preparing same

#15253
20090053680
2009-02-26

COMPOSITIONS AND METHODS FOR INDUCING SATIETY AND REDUCING CALORIC INTAKE

#15254
20090053339
2009-02-26

Composition for treatment of menopause

#15255
20090053336
2009-02-26

Method and Formulations for Treating Candidiasis Using Morinda Citrifolia

#15256
20090053335
2009-02-26

HERBAL COMPOSITIONS FOR THE INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV)

#15257
20090053334
2009-02-26

GHRELIN PRODUCTION PROMOTER

#15258
20090053332
2009-02-26

Compositions for diabetes treatment and prophylaxis

#15259
20090053329
2009-02-26

COMBINATIONS OF 5-HT2A INVERSE AGONISTS AND ANTAGONISTS WITH ANTIPSYCHOTICS

#15260
20090053319
2009-02-26

Sore Throat Relief Composition And Method of Producing Same

#15261
20090053294
2009-02-26

Anti Mineralocorticoid Therapy of Infection

#15262
20090053282
2009-02-26

Bone Grafting Method and Kit

#15263
20090053254
2009-02-26

RECOMBINANT HUMAN ALPHA-FETOPROTEIN AS AN IMMUNOSUPPRESSIVE AGENT

#15264
20090053241
2009-02-26

PDGFRβ-specific antibodies

#15265
20090053238
2009-02-26

Stabilized High Concentration Anti-Integrin alphavbeta3 Antibody Formulations

#15266
20090053234
2009-02-26

Methods of Preventing or Treating Inflammatory or Autoimmune Disorders by Administering Integrin ALPHAVBETA3 Antogonists in Combination with other Prophylactic or Therapeutic Agents

#15267
20090053221
2009-02-26

IMMUNE RESPONSE ENHANCING GLUCAN

#15268
20090053216
2009-02-26

Treatment with Anti-VEGF Antibodies

#15269
20090053208
2009-02-26

Methods and Systems for Improving Tissue Perfusion

#15270
20090053193
2009-02-26

Use of Factor VIIa for the Treatment of Burn Trauma

#15271
20090053186
2009-02-26

Therapy for primary and metastatic cancers

#15272
20090053178
2009-02-26

Use of herpes vectors for tumor therapy

#15273
20090053176
2009-02-26

New Combination 937

#15274
20090053175
2009-02-26

SUBSTITUTE PYRROLIDINE DERIVATIVES

#15275
20090053173
2009-02-26

Long acting human interferon analogs

#15276
20090053171
2009-02-26

Treatment of cellular proliferative disorders

#15277
20090053168
2009-02-26

TREATMENTS OF B-CELL PROLIFERATIVE DISORDERS

#15278
20090053163
2009-02-26

WARMING AND NONIRRITATING LUBRICANT COMPOSITIONS AND METHOD OF COMPARING IRRITATION

#15279
20090048339
2009-02-19

COMPOSITIONS OF CIS-9, TRANS-11 CONJUGATED LINOLEIC ACID AND VACCENIC ACID AND USES THEREOF

#15280
20090048302
2009-02-19

Methods and compositions for the treatment of conditions related to gastric acid secretion

#15281
20090048292
2009-02-19

SYNERGISTIC COMBINATION

#15282
20090048287
2009-02-19

Compositions useful for treating gastrointestinal motility disorders

#15283
20090048262
2009-02-19

COMBINATION OF 10-PROPARGYL-10-DEAZAAMINOPTERIN AND ERLOTINIB FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER

#15284
20090048261
2009-02-19

Pharmaceutical Composition for Treatment of Ocular Hypertension

#15285
20090048237
2009-02-19

COMPOSITIONS AND METHODS FOR PROCEDURAL SEDATION AND ANALGESIA USING ORAL TRANSMUCOSAL DOSAGE FORMS

#15286
20090048234
2009-02-19

Pharmaceutical compositions and methods for preventing, treating, or reversing neuronal dysfunction

#15287
20090048233
2009-02-19

Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination

#15288
20090048232
2009-02-19

Compositions and methods for prophylaxis and treatment of addictions

#15289
20090048216
2009-02-19

INTRAVENOUS AND ORAL DOSING OF A DIRECT-ACTING AND REVERSIBLE P2Y12 INHIBITOR

#15290
20090048215
2009-02-19

Compositions for Ameliorating a Reduced Higher Brain Function Resulting From Organic Brain Lesions

#15291
20090048205
2009-02-19

COMBINATION THERAPY WITH SYNTHETIC TRITERPENOIDS AND GEMCITABINE

#15292
20090048184
2009-02-19

Method for producing a drug extract that contains hydroxystilbene

#15293
20090048181
2009-02-19

Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis

#15294
20090048179
2009-02-19

USE OF 5-PHOSPHODIESTERASE INHIBITORS TO ENHANCE THE PERMEABILITY OF THE BLOOD-BRAIN BARRIER OF ABNORMAL BRAIN TISSUE AND THE BLOOD-TUMOR BARRIER

#15295
20090048173
2009-02-19

Use Of Dipyridamole For Treatment Of Resistance To Platelet Inhibitors

#15296
20090048170
2009-02-19

Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP)

#15297
20090048159
2009-02-19

KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF A CALRETICULIN PROTEIN TO A CELLULAR MEMBRANE

#15298
20090048156
2009-02-19

HDAC inhibitors and hormone targeted drugs for the treatment of cancer

#15299
20090048154
2009-02-19

Methods for treating diabetes

#15300
20090048153
2009-02-19

COMPOSITION FOR TREATING SULFUR MUSTARD TOXICITY AND METHODS OF USING SAME